Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segments Advances Abbott's mission to make healthcare more accessible and give people more control over their health ...

Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...

Abbott announced plans to buy Exact in November, in the largest medtech deal announced last year. Exact makes the Cologuard test, a noninvasive option to screen for colorectal cancer. The company also ...

MADISON, Wis. — The sale of Madison-based Exact Sciences to Abbott for $23 billion was finalized on Monday. Exact Sciences is best known for its in-home cancer tests, Cologuard and Oncotype DX. It was ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

New federal legislation that allows Medicare to cover the cost of cancer-screening blood tests such as those developed by Madison-based Exact Sciences promises to dramatically increase access to the ...

Madison-based Exact Sciences Corp. on Friday reported fourth-quarter earnings that missed analysts’ expectations, but its record revenue beat market watchers' predictions. Get the latest local ...